06.25.15
The surgical division of San Diego, Calif.-based DJO Global Inc. has inked a deal to purchase the Biomet Cobalt bone cement, Optivac cement mixing accessories and Discovery elbow system for the U.S. marketplace. The agreement for Zimmer Biomet Holdings Inc. to divest certain assets was part of U.S. Federal Trade Commission (FTC) requirements prior to Zimmer Holdings Inc. completing its purchase of Biomet Inc.
“These product acquisitions are a part of a broader strategy to invest in our fast growing implant business,” said Mike Mogul, CEO of DJO Global. “We believe our surgical division is poised to continue its position as the fastest growing orthopedic implant company. I have always admired Cobalt bone cement’s color features which offer better visualization and much simpler packaging and the Discovery elbow is extremely well-regarded.”
The Cobalt bone cement is used with hip, knee, shoulder, elbow and other orthopedic implant technologies. Cobalt offers a complete range of viscosities as well as antibiotic solutions for enhanced performance and patient safety, according to DJO. The unique Softpac packaging technology creates a "safer, glassless environment and the user-friendly Optivac system provide the best in modern cementing techniques for Cobalt as well as other cement technologies," company officials said in a release.
The Discovery elbow will be DJO’s first elbow technology and adds to the company’s successful upper extremity portfolio and shoulder arthroplasty products. The Discovery elbow has more than 12 years of successful clinical outcomes.
“This acquisition is very timely for us based on our disruptive entrance into the revision market with our Exprt revision knee launched at AAOS (the American Academy of Orthopaedic Surgeons annual meeting) this year and the Discovery elbow provides great breadth to our strong upper extremity portfolio,” said Brady Shirley, president of DJO Surgical. “With three major launches planned across the knee, hip and shoulder segments in each of the next three years, we are excited about our continued opportunities for growth.”
DJO Global develops medical devices for musculoskeletal health, vascular health and pain management.
--
“These product acquisitions are a part of a broader strategy to invest in our fast growing implant business,” said Mike Mogul, CEO of DJO Global. “We believe our surgical division is poised to continue its position as the fastest growing orthopedic implant company. I have always admired Cobalt bone cement’s color features which offer better visualization and much simpler packaging and the Discovery elbow is extremely well-regarded.”
The Cobalt bone cement is used with hip, knee, shoulder, elbow and other orthopedic implant technologies. Cobalt offers a complete range of viscosities as well as antibiotic solutions for enhanced performance and patient safety, according to DJO. The unique Softpac packaging technology creates a "safer, glassless environment and the user-friendly Optivac system provide the best in modern cementing techniques for Cobalt as well as other cement technologies," company officials said in a release.
The Discovery elbow will be DJO’s first elbow technology and adds to the company’s successful upper extremity portfolio and shoulder arthroplasty products. The Discovery elbow has more than 12 years of successful clinical outcomes.
“This acquisition is very timely for us based on our disruptive entrance into the revision market with our Exprt revision knee launched at AAOS (the American Academy of Orthopaedic Surgeons annual meeting) this year and the Discovery elbow provides great breadth to our strong upper extremity portfolio,” said Brady Shirley, president of DJO Surgical. “With three major launches planned across the knee, hip and shoulder segments in each of the next three years, we are excited about our continued opportunities for growth.”
DJO Global develops medical devices for musculoskeletal health, vascular health and pain management.
--